Local Interventions Can Reduce Opioid Rx After Urologic Surgery
MONDAY, April 18, 2022 (HealthDay News) — Successful reduction in opioid prescriptions...
Read More
Pharmacy
Adverse Effects Generally Mild After BNT162b2 mRNA Booster in Over 60s
MONDAY, April 18, 2022 (HealthDay News) — Adverse effects (AEs) after the booster BNT162b2...
Read More
Half of Parents Report Giving Their Child Supplements Regularly
MONDAY, April 18, 2022 (HealthDay News) — Half of parents report their child regularly has...
Read More
Most Cancer Centers Do Not Disclose Payer-Specific Prices
MONDAY, April 18, 2022 (HealthDay News) — Most U.S. National Cancer Institute-designated...
Read More
Vijoice Granted First Approval for Treatment of PROS
MONDAY, April 18, 2022 (HealthDay News) — Vijoice (alpelisib) has been granted accelerated...
Read More
PDE5 Inhibitors Prescribed for Men on Oral Nitrates for IHD
MONDAY, April 18, 2022 (HealthDay News) — For men prescribed nitrates for ischemic heart...
Read More
Axicabtagene Ciloleucel Approved for Second-Line Treatment of LBCL
FRIDAY, April 15, 2022 (HealthDay News) — Axicabtagene ciloleucel (axi-cel; Yescarta) was...
Read More
Pluvicto Approved for PSMA-Positive mCRPC
THURSDAY, April 14, 2022 (HealthDay News) — The U.S. Food and Drug Administration approved...
Read More
ACC: Empagliflozin Offers Clinical Benefit in Heart Failure
WEDNESDAY, April 13, 2022 (HealthDay News) — For patients hospitalized for acute heart...
Read More
Studies Look at Meningitis Vaccine for Preventing Gonorrhea
WEDNESDAY, April 13, 2022 (HealthDay News) — Meningitis vaccine might provide some...
Read More
First Generic of Symbicort Receives FDA Approval
TUESDAY, April 12, 2022 (HealthDay News) — The U.S. Food and Drug Administration approved...
Read More
Shorter Prophylactic Antibiotics Feasible After Clean Orthopedic Surgery
MONDAY, April 12, 2022 (HealthDay News) — Shorter antimicrobial prophylaxis duration is...
Read More
Erectile Dysfunction Meds Tied to Higher Risk for Vision Issues
MONDAY, April 11, 2022 (HealthDay News) — Regular users of phosphodiesterase type 5...
Read More
DMARDs Not Linked to Alzheimer Risk for Seniors With RA
TUESDAY, April 12, 2022 (HealthDay News) — For patients with rheumatoid arthritis aged 65...
Read More
ACC: Mavacamten Cuts Need for Surgery in Hypertrophic Cardiomyopathy
MONDAY, April 11, 2022 (HealthDay News) — For patients with obstructive hypertrophic...
Read More
Less Than Half of U.S.-Based Clinical Trials Report Race/Ethnicity
MONDAY, April 11, 2022 (HealthDay News) — Less than half of U.S.-based trials report on...
Read More
DMARD Prescribing Low for Older Adults With Rheumatoid Arthritis
MONDAY, April 11, 2022 (HealthDay News) — Older adults with rheumatoid arthritis (RA) are...
Read More
Medicare Will Only Cover Aduhelm for Patients in Clinical Trials
FRIDAY, April 8, 2022 (HealthDay News) — Medicare announced Thursday that it will limit its...
Read More
Recommendations Updated for Management of Heart Failure
FRIDAY, April 8, 2022 (HealthDay News) — In a clinical practice guideline issued by the...
Read More
Benefits of Smoking Cessation Quantified in Patients With ASCVD
FRIDAY, April 8, 2022 (HealthDay News) — For patients with established atherosclerotic...
Read More